VCEL

#1745
Vericel Corporation
35.6800
-0.31%
Setor:
Base:
Moeda do lucro:
Faixa diária
35.6800
35.6800
Faixa anual
33.5800
43.0000
Mudança diária
-0.31%
Mudança mensal
-3.02%
Mudança em 6 meses
-1.84%
Mudança anual
-1.84%
Fechamento anterior
35.7900
Open
35.6800
Bid
Ask
Low
35.6800
High
35.6800
Volume
88
Open full chart

Financials

Overview Relatórios Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Vericel Corporation

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

Notícias